Fluid Coloading and the Incidence of Hypotension
Rapid Fluid Administration and the Incidence of Hypotension Induced by Spinal Anaesthesia and Ephedrine Requirement: the Effect of Crystalloid Versus Colloid Coloading
1 other identifier
interventional
90
1 country
1
Brief Summary
This study was conducted to evaluate the effects of rapid crystalloid (Lactated Ringer's solution) or colloid (hydroxyethyl starch; HES) cohydration with a second intravenous access line on the incidence of hypotension and ephedrine requirement during spinal anaesthesia for caesarean section.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Oct 2008
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 15, 2012
CompletedFirst Posted
Study publicly available on registry
December 5, 2012
CompletedJanuary 15, 2014
January 1, 2014
2.8 years
November 15, 2012
January 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rapid fluid administration and the incidence of hypotension induced by spinal anaesthesia and ephedrine requirement: the effect of crystalloid versus colloid coloading
The primary study endpoint was the ephedrine requirement (incidence of hypotension).
Four Years
Study Arms (3)
No coloading (Group E)
PLACEBO COMPARATORPlacebo comparator
Cristalloid (Lactated Ringer) Coloading
ACTIVE COMPARATORCristalloid (Lactated Ringer's) Coloading (Group L)
Colloid (HES) coloading
ACTIVE COMPARATORColloid (HES) coloading (Group C)
Interventions
Cristalloid coloading (Group L) Colloid coloading (Group C) No coloading (Group E)Placebo Comparator
Eligibility Criteria
You may qualify if:
- elective caesarean section under spinal anaesthesia
You may not qualify if:
- Significant coexisting disease such as; pre-eclampsia and hepato-renal disease,
- Pregnancy preinduced hypertension,
- Being in active labour or requiring emergency caesarean section,
- Any contraindication to regional anaesthesia such as local infection or bleeding disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hakki Unlugenc
Adana, 01330, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hakki Unlugenc, Prof Dr
Cukurova University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Dr.
Study Record Dates
First Submitted
November 15, 2012
First Posted
December 5, 2012
Study Start
October 1, 2008
Primary Completion
August 1, 2011
Study Completion
June 1, 2012
Last Updated
January 15, 2014
Record last verified: 2014-01